- Home
- LTH vs AXSM Comparison
LTH vs AXSM Comparison
Compare LTH & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LTH | AXSM |
|---|---|---|
| Founded | 1992 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.9B |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | LTH | AXSM |
|---|---|---|
| Price | $27.87 | $151.76 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 20 |
| Target Price | $36.79 | ★ $176.00 |
| AVG Volume (30 Days) | ★ 2.3M | 595.0K |
| Earning Date | 11-04-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.46 | N/A |
| EPS | ★ 1.28 | N/A |
| Revenue | ★ $2,913,442,000.00 | $561,263,000.00 |
| Revenue This Year | $14.65 | $63.66 |
| Revenue Next Year | $10.92 | $54.46 |
| P/E Ratio | $21.74 | ★ N/A |
| Revenue Growth | 15.77 | ★ 65.83 |
| 52 Week Low | $21.49 | $75.56 |
| 52 Week High | $34.99 | $152.94 |
Technical Indicators
Market Signals| Indicator | LTH | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 65.92 | 71.28 |
| Support Level | $24.46 | $147.97 |
| Resistance Level | $26.29 | $152.94 |
| Average True Range (ATR) | 0.71 | 4.91 |
| MACD | 0.37 | 0.48 |
| Stochastic Oscillator | 91.95 | 93.17 |
Price Performance
Historical ComparisonAbout LTH Life Time Group Holdings Inc.
Life Time Group Holdings Inc is a lifestyle and leisure brand offering health, fitness, and wellness experiences to a community. It is engaged in designing, building, and operating distinctive and large, multi-use sports and athletic, professional fitness, family recreation, and spa centers in a resort-like environment, principally in residential locations of metropolitan areas in the United States and Canada.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.